FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2946469429> ?p ?o ?g. }

• W2946469429 abstract "Objectives We previously reported that Golgi phosphoprotein 3 (GOLPH3) promotes glioma progression by inhibiting EGFR endocytosis and degradation, leading to EGFR accumulation and PI3K-AKT pathway over-activation. In the current study, we examine whether GOLPH3 affects the response of glioma cells to gefitinib, an EGFR selective inhibitor. Materials and methods The expression of GOLPH3 and EGFR in glioma cells was detected by immunofluorescence and immunoblotting. The cell viability or growth in vitro was determined by CCK-8, EdU incorporation and clonogenic assays. The primary glioma cells were cultured by trypsin and mechanical digestion. The transwell invasion assay was used to examine the primary glioma cell motility. Intracranial glioma model in nude mice were established to explore the sensitivity of gefitinib to GOLPH3 high cancer cells in vivo. Results Both the immortalized and primary glioma cells with GOLPH3 over-expression hold higher EGFR protein levels on the cell membrane and exhibited higher sensitivity to gefitinib. In addition, primary glioma cells with higher GOLPH3 level exhibited stronger proliferation behaviour. Importantly, GOLPH3 enhanced the anti-tumour effect of gefitinib in vivo. Consistently, after gefitinib treatment, tumours derived from GOLPH3 over-expression cells exhibited lower Ki67-positive and higher cleaved caspase-3-positive cells than control tumours. Conclusions Our results demonstrate that GOLPH3 increases the sensitivity of glioma cells to gefitinib. Our study provides foundation for further exploring whether GOLPH3 high gliomas will be more sensitive to anti-EGFR therapy in clinic and give ideas for developing new possible treatments for individual glioma patients." @default.
• W2946469429 created "2019-05-29" @default.
• W2946469429 creator A5003642180 @default.
• W2946469429 creator A5049341927 @default.
• W2946469429 creator A5049655034 @default.
• W2946469429 creator A5056101043 @default.
• W2946469429 creator A5056897117 @default.
• W2946469429 creator A5058863593 @default.
• W2946469429 creator A5071773009 @default.
• W2946469429 creator A5085205645 @default.
• W2946469429 creator A5089711982 @default.
• W2946469429 date "2019-05-16" @default.
• W2946469429 modified "2023-10-17" @default.
• W2946469429 title "Golgi phosphoprotein 3 sensitizes the tumour suppression effect of gefitinib on gliomas" @default.
• W2946469429 cites W1221919067 @default.
• W2946469429 cites W1956553072 @default.
• W2946469429 cites W1967394241 @default.
• W2946469429 cites W1969990870 @default.
• W2946469429 cites W1996339481 @default.
• W2946469429 cites W1998033835 @default.
• W2946469429 cites W1999512731 @default.
• W2946469429 cites W2036044314 @default.
• W2946469429 cites W2037173620 @default.
• W2946469429 cites W2048391838 @default.
• W2946469429 cites W2082315732 @default.
• W2946469429 cites W2086776925 @default.
• W2946469429 cites W2096287682 @default.
• W2946469429 cites W2096885935 @default.
• W2946469429 cites W2098529801 @default.
• W2946469429 cites W2109490882 @default.
• W2946469429 cites W2111946930 @default.
• W2946469429 cites W2123359660 @default.
• W2946469429 cites W2125905711 @default.
• W2946469429 cites W2146012070 @default.
• W2946469429 cites W2148163986 @default.
• W2946469429 cites W2152269520 @default.
• W2946469429 cites W2158543265 @default.
• W2946469429 cites W2169663671 @default.
• W2946469429 cites W2284758093 @default.
• W2946469429 cites W2366536035 @default.
• W2946469429 cites W2410867350 @default.
• W2946469429 cites W2620951738 @default.
• W2946469429 cites W2756569016 @default.
• W2946469429 cites W2781860009 @default.
• W2946469429 cites W2847268179 @default.
• W2946469429 cites W2894683020 @default.
• W2946469429 cites W2897353712 @default.
• W2946469429 cites W3141418844 @default.
• W2946469429 cites W40421932 @default.
• W2946469429 cites W4243496626 @default.
• W2946469429 doi "https://doi.org/10.1111/cpr.12636" @default.
• W2946469429 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6669003" @default.
• W2946469429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31094020" @default.
• W2946469429 hasPublicationYear "2019" @default.
• W2946469429 type Work @default.
• W2946469429 sameAs 2946469429 @default.
• W2946469429 citedByCount "14" @default.
• W2946469429 countsByYear W29464694292020 @default.
• W2946469429 countsByYear W29464694292021 @default.
• W2946469429 countsByYear W29464694292022 @default.
• W2946469429 countsByYear W29464694292023 @default.
• W2946469429 crossrefType "journal-article" @default.
• W2946469429 hasAuthorship W2946469429A5003642180 @default.
• W2946469429 hasAuthorship W2946469429A5049341927 @default.
• W2946469429 hasAuthorship W2946469429A5049655034 @default.
• W2946469429 hasAuthorship W2946469429A5056101043 @default.
• W2946469429 hasAuthorship W2946469429A5056897117 @default.
• W2946469429 hasAuthorship W2946469429A5058863593 @default.
• W2946469429 hasAuthorship W2946469429A5071773009 @default.
• W2946469429 hasAuthorship W2946469429A5085205645 @default.
• W2946469429 hasAuthorship W2946469429A5089711982 @default.
• W2946469429 hasBestOaLocation W29464694291 @default.
• W2946469429 hasConcept C119062480 @default.
• W2946469429 hasConcept C11960822 @default.
• W2946469429 hasConcept C121608353 @default.
• W2946469429 hasConcept C126322002 @default.
• W2946469429 hasConcept C1491633281 @default.
• W2946469429 hasConcept C185592680 @default.
• W2946469429 hasConcept C2777061661 @default.
• W2946469429 hasConcept C2779438470 @default.
• W2946469429 hasConcept C2780580887 @default.
• W2946469429 hasConcept C502942594 @default.
• W2946469429 hasConcept C55493867 @default.
• W2946469429 hasConcept C71924100 @default.
• W2946469429 hasConcept C86803240 @default.
• W2946469429 hasConcept C95444343 @default.
• W2946469429 hasConceptScore W2946469429C119062480 @default.
• W2946469429 hasConceptScore W2946469429C11960822 @default.
• W2946469429 hasConceptScore W2946469429C121608353 @default.
• W2946469429 hasConceptScore W2946469429C126322002 @default.
• W2946469429 hasConceptScore W2946469429C1491633281 @default.
• W2946469429 hasConceptScore W2946469429C185592680 @default.
• W2946469429 hasConceptScore W2946469429C2777061661 @default.
• W2946469429 hasConceptScore W2946469429C2779438470 @default.
• W2946469429 hasConceptScore W2946469429C2780580887 @default.
• W2946469429 hasConceptScore W2946469429C502942594 @default.
• W2946469429 hasConceptScore W2946469429C55493867 @default.
• W2946469429 hasConceptScore W2946469429C71924100 @default.
• W2946469429 hasConceptScore W2946469429C86803240 @default.
• W2946469429 hasConceptScore W2946469429C95444343 @default.

• next